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Background: Early age at illness onset has been viewed as an important liability marker for schizophrenia, which
may be associatedwith an increased genetic vulnerability. A twin approach can be valuable, because it allows for
the investigation of speciﬁc illness markers in individuals with a shared genetic background.
Methods:We linked nationwide registers to identify a cohort of twin pairs born in Denmark from 1951 to
2000 (N = 31,524 pairs), where one or both twins had a diagnosis in the schizophrenia spectrum. We de-
ﬁned two groups consisting of;N=788 twin pairs (affectedwith schizophrenia spectrum) and a subsample
of N = 448 (affected with schizophrenia). Survival analysis was applied to investigate the effect of age at
illness onset.
Findings:We found that early age at illness onset compared to later onset in the ﬁrst diagnosed twin can be
considered a major risk factor for developing schizophrenia in the second twin. Additionally, we found that
the stronger genetic component in MZ twins compared to DZ twins is manifested in the proximity of
assigned diagnosis within pairs.
Discussion: Early onset schizophrenia could be linked to a more severe genetic predisposition, indicating
that age might be perceived as a clinical marker for genetic vulnerability for the illness.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Age at onset has been proposed as themost important characteristic
of schizophrenia that provides knowledge about the origin of the disor-
der (DeLisi, 1992). Studies have reported early age at illness onset to be
characterized by a worse course of illness, with more positive family
history of psychosis and an increased risk of illness in siblings
(Rabinowitz et al., 2006; Byrne, 2002; Hosmer et al., 2008; Husted et
al., 2006). Therefore it can be viewed as a distinct phenotypic liability
marker for schizophrenia because it may represent a speciﬁc subtype
of the disorder (Goldberg et al., 2011). The risk of developing
schizophrenia has consistently been reported higher in males (Aleman
et al., 2003), while the peak in age at onset is equal between sexes at
around age 22, with a difference in the mean age at onset being later
for females (Pedersen et al., 2014; van der Werf et al., 2014; Thorup et
al., 2007). This underlines the importance of addressing possible sex dif-
ferenceswhen studying illness vulnerability. In this regard, ameta-anal-
ysis found that the presence of a family history of psychosis inﬂuenced
an earlier age at onset in both sexes compared to families without a his-
tory of psychosis in which only the male sex was associated with early
illness onset (Esterberg et al., 2010). A recent study focused on illness
course and did not ﬁnd an association between gender and age at
onset on the course of illness when adjusting for symptom severity at
illness presentation, indicating that these features offer little prognostic
value (Drake et al., 2016). This suggests that early age at illness onset
might be a relevant clinical marker for increased genetic vulnerability
in which sex may be a modifying factor, rather than a marker for symp-
tom severity and illness course.
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Exposure to speciﬁc environmental factors increases the risk to de-
velop schizophrenia in vulnerable individuals (van Os et al., 2010),
thus environmental and genetic factors may both inﬂuence age at ill-
ness onset in schizophrenia. Accumulated exposures such as obstetric
complications, trauma, urbanicity and cannabis use seem to have a
major impact on lowering age at onset in male patients (Stepniak et
al., 2014). A Swedish register-based study combined the study of envi-
ronmental and genetic risk, by measuring sibling risk of schizophrenia
both in affected and unaffected families and described an increased
risk in siblings in affected families compared to unaffected families.
The risk was modiﬁed by factors like higher age at onset in probands,
advanced paternal age and immigrant status of parents (Svensson et
al., 2012). These ﬁndings support a role for environmental risk factors
in age at schizophrenia onset. Speciﬁc genetic polymorphisms are also
associated with early age of schizophrenia onset, although only present
in male patients (Hänninen et al., 2007; Yuan et al., 2013). A GWAS
study could not draw signiﬁcant conclusions regarding genetic associa-
tion with age at onset, severity of disorder or disease associations by
family history of schizophrenia and sex (Bergen et al., 2014); however,
a more recent study identiﬁed a correlation between speciﬁc genetic
variations and a lower age at schizophrenia onset (Chow et al., 2016).
In conclusion, there is a lack of evidence for a simple genetic association
between the timing of illness onset and sex or family history, or to what
extent genetic risk affects age of illness onset in both sexes.
In general, twin studies allow for the study of phenotypic, endo-
phenotypic and biological discordance in individuals with a shared ge-
netic background, which makes it a valuable tool in studying complex
human traits and disorders such as schizophrenia. The classic twin
study compares phenotypic resemblances of monozygotic (MZ) and di-
zygotic (DZ) twins to identify genetic variation in disease susceptibility
(Boomsma et al., 2002). A twin design can examine “age at illness onset”
as a speciﬁc liability marker of schizophrenia, in relation to the genetic
impact on disease liability, and furthermore investigate possible sex
differences.
This study aims to examine age at illness onset and risk of schizo-
phrenia and schizophrenia spectrumdisorders in a national twin cohort
identiﬁed in the Danish Twin Register using information from the
Danish Psychiatric Central Research Register. In the study we will
focus on two diagnostic categories; a narrowdeﬁnition of schizophrenia
as outlined in ICD-8 and ICD-10, and a broader phenotypic outcome
representing the schizophrenia spectrum in ICD-8 and ICD-10. Speciﬁ-
cally, we will investigate if an early onset of schizophrenia and schizo-
phrenia spectrum in the ﬁrst diagnosed twin (b22 years of age)
increases the risk of illness in the second twin. In addition, we examine
the importance of genetic effects in the timing of illness onset in twin
pairs by testing whether the higher genetic similarity in MZ twins com-
pared to DZ twins is associated with closer proximity of assignment of
diagnoses in the twin pairs.
2. Methods
The study is approved by the Danish Data Protection Agency and the
Danish National Board of Health.
2.1. National Registers
The present sample is based on linkage of two nationwide registers,
the Danish Twin Register and the Danish Psychiatric Research Register,
thereby identifying a sample of twin pairs born 1951–2000. At birth all
individuals are registered with a unique identiﬁcation number in the
Danish Central Civil Registration System, andusing this register it is pos-
sible to identify all individuals across registers (Pedersen et al., 2006).
The Danish Twin Register includes twin pairs born in Denmark from
1870 onwards, it was initiated in 1954 and the ascertainment of live-
born twin pairs is complete from 1968 (Skytthe et al., 2011). Zygosity
information is not available from all twins in the register (Skytthe et
al., 2011). Twins with unknown zygosity (UZ) are removed from the
sample, since our aim is to investigate the genetic predisposition in re-
lation to early illness onset, and in UZ twins the degree of shared genetic
material is unknown. The Danish Psychiatric Central Case Register con-
tains information on all admissions to a psychiatric facility in Denmark;
itwas initiated in 1938, computerized in 1969 and from1995 outpatient
contacts were included in the register (Mors et al., 2011).
2.2. Disease Classiﬁcations
From 1969 to 1993 the ICD-8 classiﬁcation system was used while
the ICD-10 was used from 1994 onwards (World Health Organization,
1967, 1992). For this study schizophrenia was deﬁned as a main or sec-
ondary lifetime diagnosis in the following ICD versions (ICD-10: F20.xx
and ICD-8: 295 (excluding 295.79, schizoaffective disorder)) and
schizophrenia spectrumwas deﬁned as amain or secondary lifetime di-
agnosis in (ICD-10: F2x.xx and ICD-8: 295, 297, 29829, 29839, 29889,
29899, 29905, 29909, 30109, 30129). We deﬁned a lifetime diagnosis
as a diagnosis received at any time during the planned observation pe-
riod, in this study, from birth until June 1st, 2011. Speciﬁcally this is de-
ﬁned as the ﬁrst date of diagnosis of schizophrenia, thus ignoring a
possible diagnosis in the schizophrenia spectrum before this date. For
schizophrenia spectrum it is the ﬁrst date of diagnosis.
2.3. Statistical Analysis
Survival analysis (i.e. Cox proportional hazard modeling) was ap-
plied to investigate the effect of age at onset (below/above age 22) of
the ﬁrst diagnosed twin on illness outcome in the second twin
(Hosmer et al., 2008). The cut-off point at age 22 is based on the peak
in incidence rates at this age (Thorup et al., 2007; van der Werf et al.,
2014) and a study that validated two distinct illness subtypes with an
onset before and after age 22 when observing the distribution of age
at onset in a large clinical sample of patients with schizophrenia
(Panariello et al., 2010). To examine a possible association of increased
risk of illness with decreasing age intervals we further divided the age
at onset in the ﬁrst diagnosed twin into 4 categories; b18, [18–22),
[22−30) and [30, onwards). Survival analysis was also applied investi-
gating the age intervals. Each co-twinwas followed frombirth until date
of schizophrenia, censoring or death. By estimating zygosity-speciﬁc
Kaplan-Meier curves for the affected twin pairs we aim to investigate
if the proximity between age at onset in twin pairs mirrors the higher
genetic similarity among MZ pairs compared to DZ pairs. Data analyses
were carried out using Stata version 13. The models were all adjusted
for zygosity and sex to minimize bias.
2.4. Role of the Funding Source
The study sponsor had no role in study design, data analysis, data in-
terpretation or writing of the paper.
3. Results
All individuals were followed from the computerization of the
Danish Psychiatric Central Research Register in 1969 until June 1st,
2011. The present dataset contains MZ and DZ twin pairs born in Den-
mark from 1951 to 2000, N = 31,524 pairs. Of these N = 788 pairs
(842 individuals) were affected with schizophrenia spectrum disorder
and a subsample of N = 448 pairs (472 individuals) were affected
with schizophrenia. The sample characteristics are described in Table 1.
As mentioned in method section all UZ twin pairs have been removed
in the ﬁnal sample of N= 31,524 twin pairs. This includes N= 138 UZ
pairs (157 individuals) affected with schizophrenia spectrum and a sub-
sample of N=76 UZ pairs (88 individuals) affected with schizophrenia.
Fig. 1 displays the distribution of age at onset among all twins affect-
ed with schizophrenia and schizophrenia spectrum. We observed that
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the age range is wider for the schizophrenia spectrum compared to
schizophrenia and that spectrumdisorders appear tohave a slightly ear-
lier onset than the narrow illness deﬁnition.
The risk of developing schizophrenia in the second twin is 4.7 times
higher if the ﬁrst twin has an early onset of schizophrenia, Table 2a;
Hazard ratio (HR) = 4.7, 95% CI = (2.05–10.1). The risk is 4.4 times
higher in schizophrenia spectrum (HR = 4.39, 95% CI = (2.56–7.52)).
When adding a correction for sex in the second twin no signiﬁcant
change in the effect of zygosity and age at onset was observed for the
risk of either schizophrenia or schizophrenia spectrum (Table 2b). The
risk of both illness categories was slightly higher in women than in
men but not signiﬁcant (Table 2b). In addition an interaction term be-
tween sex in the second twin and age at onset was added to the
model. It has no effect on the risk of schizophrenia spectrum disorder
but did reduce the main effect of age at onset on risk of schizophrenia
(Table 2c). A putative link between sex in the second twin and onset
of schizophrenia (but not schizophrenia spectrum) is also seen when
female and male twins are analyzed separately. We observed that the
effect of early onset in the ﬁrst twin on risk of disease in the second
twin ismarkedly larger in females than inmales. The effect is signiﬁcant
but there is uncertainty about the size of the effect because of wide con-
ﬁdence intervals (Females: HR = 8·66, CI = (2.65–28.33)) (Table 3).
One pair was excluded because the twins were diagnosed on the same
day, hence the ﬁnal analyses included a sample of N = 447 and N =
787 pairs for analysis in schizophrenia and schizophrenia spectrum re-
spectively. The total follow-up time in co-twins was 18,385.36 and
32,382.19 years for schizophrenia and schizophrenia spectrum respec-
tively; this corresponds to 41.13 and 41.14 years per co-twin.
Dividing the age at onset in the ﬁrst diagnosed twin into four inter-
vals; i.e. b18, [18–22), [22–30) and [30, onwards) shows that co-twins
Table 1
Frequencies (percentage) describing the two samples of affected twin pairs with schizophrenia (N= 448) and schizophrenia spectrum (N= 788) respectively.
Schizophrenia (N= 448) Schizophrenia spectrum (N= 788)
MZ (N= 81 pairs) DZ (N= 368) MZ (N= 158 pairs) DZ (N= 631 pairs)
Concordant pairs 12 (14.81) 12 (3.26) 23 (14.56) 31 (4.91)
Discordant pairs 69 (85.19) 355 (96.47) 135 (85.44) 599 (94.93)
No. of individuals
Males 82 (50.61) 400 (54.35) 170 (53.80) 652 (51.66)
Females 80 (49.38) 334 (45.38) 146 (46.20) 608 (48.18)
Schizophrenia (N= 447)a MZ (N= 81 pairs) DZ (N= 367 pairs)
Age at onset of ﬁrst diagnosed twin SZ absent in second twin SZ in second twin SZ absent in second twin SZ in second twin
b18 4 (4.94) 0 (0.00) 25 (6.81) 2 (0.54)
[18–22) 10 (12.35) 4 (4.94) 61 (16.62) 5 (1.36)
[22–30) 22 (27.16) 6 (7.41) 129 (35.15) 2 (0.54)
≥30 33 (40.74) 1 (1.23) 140 (38.15) 3 (0.82)
Schizophrenia spectrum (N= 787)b MZ (N= 158 pairs) DZ (N= 630 pairs)
Age at onset of ﬁrst diagnosed twin SZ absent in second twin SZ in second twin SZ absent in second twin SZ in second twin
b18 11 (6.96) 3 (1.90) 53 (8.41) 5 (0.79)
[18–22) 15 (9.49) 5 (3.16) 107 (16.98) 10 (1.59)
[22–30) 42 (26.58) 10 (6.33) 190 (30.16) 8 (1.27)
≥30 67 (42.41) 4 (2.53) 249 (39.52) 8 (1.27)
a N= 487, one pair is excluded since the diagnosis was assigned at the same day.
b N= 787, one pair is excluded since the diagnosis was assigned at the same day.
Fig. 1. Age at onset among all twins affected with schizophrenia (N=448) and schizophrenia spectrum (N=788) in twin pairs born 1951–2000 and identiﬁed by linkage of the Danish
Twin Register and the Danish Psychiatric Central Research Register.
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within the ﬁrst three intervals (b18, [18–22), [22–30)) all have an in-
creased risk of schizophrenia (Table 4). In fact, having a diagnosed co-
twin with onset below 18 years increases the risk of illness 7 times
([1.3–39]), likewise onset from 18 to 22 years increases the risk off ill-
ness 9 times ([2.8–30.9]). Results were similar for schizophrenia spec-
trum with a signiﬁcantly increased risk of schizophrenia spectrum in
the co-twin with lower age at onset of the diagnosed twin. Upon divid-
ing the sample into four age intervals, the sample sizewas smaller and it
was not possible to apply the same analysis strategy (with gender spe-
ciﬁc analysis and interaction terms) as in Table 2.
Kaplan-Meier curves documented a closer proximity in time of diag-
noses among MZ twins than DZ twins following both the onset of
schizophrenia and schizophrenia spectrum disorder in the co-twin
(Fig. 2a; Chi2 = 15.12, P b 0.001, Fig. 2b; Chi2 = 16.55, P b 0.001).
4. Discussion
A key ﬁnding in this study is the almost ﬁve times increased risk of
schizophrenia in the second twin when the ﬁrst diagnosed twin was
under the age of 22 at the ﬁrst appearance of illness, with a more pro-
nounced effect in female twins. Further division of the age at onset of
schizophrenia spectrumdisorders into four age intervals, led to a signif-
icant increase in illness risk in the second twin with decreasing age in
the ﬁrst diagnosed twin. Furthermore, we conﬁrmed that the stronger
genetic component in MZ twins than in DZ twins is manifested in the
proximity of diagnosis within pairs. The key strength of this study is
the inclusion of representative data from a nationwide twin cohort con-
stituting the largest and most updated twin sample in schizophrenia
research.
Our main ﬁnding indicates, that early illness onset can be perceived
as a clinical marker for increased genetic vulnerability. This is in line
with a study showing that increased family illness load predicted an
earlier age at illness onset (Goldberg et al., 2011) and a Swedish regis-
ter-based study investigating age-speciﬁc risk of illnesswith the highest
risk found in the youngest age groups (Li et al., 2007). In our study the
risk seemed more prominent in females, suggesting that early onset in
females is caused by a higher genetic burden. This is consistent with fe-
males in general having a lower risk of developing schizophrenia than
Table 2
The risk (hazard ratio (HR)) associatedwith developing schizophrenia/schizophrenia spectrum in the second twin if the ﬁrst twin had onset of schizophrenia (N=447 pairs)/schizophre-
nia spectrum (N=787 pairs) before age 22 in a national cohort of 31,524 twin pairs born 1951–2000 and identiﬁed by linkage of Danish Twin Register and the Danish Psychiatric Central
Research Register. One pair is excluded because the two twins are diagnosed on the same day. (a) HR associatedwith schizophrenia/schizophrenia spectrum in the second twin predicted
by age at onset in the ﬁrst diagnosed twin, adjusted for zygosity. (b) HR associated with schizophrenia/schizophrenia spectrum in the second twin predicted by age at onset in the ﬁrst
diagnosed twin, adjusted for zygosity and sex. (c) HR associated with schizophrenia/schizophrenia spectrum in the second twin predicted by age at onset in the ﬁrst diagnosed twin, ad-
justed for zygosity with an interaction between sex and age at onset is added.
Schizophrenia (N= 447) Schizophrenia spectrum (N= 787)
HR Std. error P-value 95% CI HR Std. error P-value 95% CI
a
Age of onset ≥ 22 Reference – – – Reference – – –
Age of onset b 22 4.69 1.98 b0.001 2.05–10.74 4.39 1.21 b0.001 2.56–7.52
Dizygotic Reference – – – Reference – – –
Monozygotic 5.65 2.39 b0.001 2.46–12.95 4.19 1.21 b0.001 2.38–7.38
b
Age of onset ≥ 22 Reference – – – Reference – – –
Age of onset b 22 4.80 2.04 b0.001 2.08–11.02 4.40 1.21 b0.001 2.57–7.55
Dizygotic Reference – – – Reference – – –
Monozygotic 5.65 2.40 b0.001 2.46–12.97 4.20 1.21 b0.001 2.38–7.40
Male Reference – – – Reference – – –
Female 1.29 0.54 n.s. 0.57–2.94 1·52 0.43 n.s. 0.88–2.63
c
Age of onset ≥ 22 Reference – – – Reference – – –
Age of onset b 22 2.51 1.58 n.s. 0.73–8.61 4.22 1.80 b0.05 1.83–9.74
Dizygotic Reference – – – Reference – – –
Monozygotic 5.88 2.50 b0.001 2.55–13.53 4.21 1.22 b0.001 2.38–7.43
Male Reference – – – Reference – – –
Female 0.72 0.42 n.s. 0.23–2.26 1.47 0.54 n.s. 0.72–3.00
Interaction
Age of onset/female
3.46 2.98 n.s. 0.64–18.70 1.08 0.62 n.s. 0.35–3.30
Age at onset refers to the age at onset in the ﬁrst diagnosed twin, while sex refers to the second twin.
Table 3
The sex-speciﬁc risk (hazard ratio (HR)) associated with developing schizophrenia (N=447)/schizophrenia spectrum (N=787) in the second twin, if the ﬁrst twin had an illness onset
before age 22 in a cohort of twins born 1951–2000 identiﬁed by linkage of Danish Twin Register and the Danish Psychiatric Central Research Register.
HR Std. error P-value 95% CI HR Std. error P-value 95% CI
Females Schizophrenia (N= 215) Schizophrenia spectrum (N= 386)
Age of onset ≥ 22 Reference – – – Reference – – –
Age of onset b 22 8.66 5.24 b0.001 2.65–28.33 4.66 1.75 b0.001 2.23–9.72
Dizygotic Reference – – – Reference – – –
Monozygotic 5.26 3.23 b0.01 1.58–17.51 4.15 1.70 b0.05 1.86–0.26
Males Schizophrenia (N= 232) Schizophrenia spectrum (N= 401)
Age of onset ≥ 22 Reference – – – Reference – – –
Age of onset b 22 2.53 1.59 n.s. 0.74–8.70 4.07 1.68 b0.05 1.81–9.14
Dizygotic Reference – – – Reference – – –
Monozygotic 6.91 4.20 b0.01 2.10–22.76 4.28 1.77 b0.001 1.90–9.64
The hazard ratio (HR) associatedwith schizophrenia/schizophrenia spectrum in the second twin predicted by age at disease onset in the ﬁrst diagnosed twin, adjusted for zygosity and sex
of the second twin.
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males (Pedersen et al., 2014) and therebymay require a stronger genet-
ic contribution to affect the predisposition to illness. Sex difference was
not apparent for the broader illness category. The association of
increased familial aggregation of schizophrenia with a younger age
at onset was also described in a meta-analysis (Esterberg et al.,
2010).This applied to both sexes; however but without familial aggre-
gationmales had a signiﬁcantly earlier onset. The results further under-
line the importance of genetic factors to affect early illness onset in
females, whereas an early onset for the male sex to a larger extent
could be inﬂuenced by other risk factors, such as environmental risks.
This is supported by evidence from a study showing that early onset
cases are more likely to be males that have experienced obstetric com-
plications and had a history of drug abuse and low academic perfor-
mance (Liu et al., 2013), and from a study in male patients where
accumulated environmental risks signiﬁcantly lowered age at illness
onset (Stepniak et al., 2014). In conclusion, these ﬁndings indicate that
female sex may modify the association with early onset of schizophre-
nia and increase risk and supports a role for sex-speciﬁc genetic interac-
tions. All though the ﬁndings are signiﬁcant, a speciﬁc limitation is the
low number of cases (concordant pairs) when dividing the dataset
into both illness onset before and after age 22 and sex. Other studies
support differences in illness presentation between males and females
regarding premorbid adjustment and symptom severity but not to ill-
ness course (Goldberg et al., 2011; Drake et al., 2016). However, there
is contradictory evidence for a speciﬁc genetic association to sex differ-
ences in schizophrenia (Hänninen et al., 2007; Yuan et al., 2013; Bergen
et al., 2014; Chow et al., 2016). When dividing the age at onset in four
intervals wewere able to examine the possible presence of amore step-
wise increase of risk rather than the dichotomous cut in before and after
age 22. Here we found an increasing risk of illness in the second twin
with decreasing age at onset in the ﬁrst diagnosed twin (Table 4). In
general the conﬁdence intervals are rather wide, which reﬂect a small
number of cases in each age group, especially when studying the nar-
row illness deﬁnition (Table 1). In the schizophrenia spectrum category
where more cases are included, all results are signiﬁcant and have
smaller conﬁdence intervals.
In this study we are unable to estimate the contribution of environ-
mental factors to schizophrenia risk.We interpret the overall higher risk
inMZ twins (in all our results) as indication of the importance of genetic
factors according to the classical twin model (Boomsma et al., 2002).
Furthermore, one assumption in the classical twin model is the “Equal
Environment Assumption”, i.e. that DZ twins share their environment
to the same extend as MZ twins (Rijsdijk and Sham, 2002). This has
been subject to debate, and if MZ twins do share a more equal
Table 4
The risk (hazard ratio (HR)) associated with developing schizophrenia/schizophrenia spectrum in the second twin, divided into intervals (b18, 18–22, 22–30, N30) regarding the age at
onset in theﬁrst diagnosed twin (schizophreniaN=447pairs)/schizophrenia spectrum (N=787pairs), based on a national cohort of 31,524 twin pairs born 1951–2000 and identiﬁedby
linkage of Danish Twin Register and the Danish Psychiatric Central Research Register.
Schizophrenia (N= 447) Schizophrenia spectrum (N= 787)
HR Std. error P-value 95% CI HR Std. error P-value 95% CI
AAO ≥ 30 Reference – – – Reference – – –
AAO b 18 7.07 6.16 b0.05 [1.28–38.99] 10.72 4.96 b0.001 [4.33–26.54]
AAO [18–22) 9.25 5.70 b0.001 [2.76–30.94] 6.06 2.40 b0.001 [2.79–13.15]
AAO [22–30) 2.96 1.83 n.s. [0.88–9.94] 2.72 1.02 b0.01 [1.30–5.66]
Gender
°Male Reference – – – Reference – – –
°Female 1.44 0.61 n.s. [0.62–3.32] 1.54 0.43 n.s. [0.89–2.65]
Dizygotic Reference – – – Reference – – –
Monozygotic 5.83 2.48 b0.001 [2.54–13.40] 4.18 1.21 b0.001 [2.37–7.35]
Fig. 2. Time difference between onset of diagnosis in affected twin pairs with schizophrenia (a; N= 447 twin pairs) and schizophrenia spectrum (b; N= 787 twin pairs) respectively,
based on information from linkage of the Danish Twin Register and the Danish Psychiatric Central Research Register in a national cohort of twin pairs born 1951–2000.
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environment than DZ twins, then the impact of genetic factors on illness
risk can be overestimated. The observation of signiﬁcant genetic effects
does not insinuate that the environmental risks are less important be-
cause schizophrenia is a complex disorder with a heterogeneous clinical
presentation (Owen et al., 2016). Indeed it is inﬂuenced by both genetic
and several environmental risk factors and the complex interaction be-
tween them (Davis et al., 2016).
We showed that the almost identical genetic background in MZ
twins compared with the average genetic identity of 50% in DZ twins
is reﬂected in higher concordance with respect to time at illness onset
within pairs, i.e. in MZ twins the observed time span between the as-
signments of the diagnoses is shorter than in DZ twins (Fig. 2). To our
knowledge, the association of a shared genetic background and timing
of illness onset in twins has not been demonstrated previously. A
study of genetic inﬂuence on subtypes of schizophrenia, such as age at
onset, did not show a simple genetic architecture in relation to early ill-
ness onset (Bergen et al., 2014), but our results indicate the importance
of genetic effects in the pattern of illness onset in twin pairs. The Kaplan
Meier curve in Fig. 2a and b does not stratify between the outcome and
possible competing risks. Accordingly, the absolute ﬁgures on the Y-axis
must be taken with reservation. The most important competing risk in
this study is occurrence of death before having a possible diagnosis of
schizophrenia spectrum. In this study, we can assume that censoring
and competing risks will be the same for MZ and DZ twins, thus we ex-
pect the result of a greater proximity of schizophrenia spectrum disor-
ders in MZ twins compared to DZ twins, to be governed by genetic
effects rather than competing risks.
The Kaplan-Meier curves illustrating schizophrenia and schizophre-
nia spectrum are similar (Fig. 2a and b). This indicates that the timing of
illness onset does not seem to differ when comparing a narrow illness
deﬁnition to the broader including the schizophrenia spectrum. Also
the HR estimated in Tables 1–3 does not indicate profound differences
in the two diagnostic outcomes. In general, our results support that
the genetic susceptibility covers a broad phenotypic outcome in the
full spectrum of schizophrenia. Previous studies have also conﬁrmed
the importance of a broad approach when estimating the risk of severe
mental illness in relatives (Mortensen et al., 2010; Rasic et al., 2014).
General strengths and limitations: The present sample consists of
twin pairs from a comprehensive, nationwide register and is as such
less liable to ascertainment bias. Removing twin pairs with UZ from
the estimates might introduce a selection bias, but since the degree of
shared genetic material is unknown in UZ twins, it is not possible to
study genetic importance in risk of early illness onset. As a national reg-
ister, the Danish Psychiatric Central Research Register is highly repre-
sentative of patients with schizophrenia in Denmark since only a
minimal number of patients are treated privately (Mors et al., 2011).
Furthermore, a recent study demonstrated a high validity of the register
diagnosis in schizophrenia consolidating the validity and consistency of
the register diagnosis (Uggerby et al., 2013). Despite the comprehensive
register data undiagnosed cases could exist. Additionally, the register-
based data does not provide speciﬁc information on the twin pairs,
thereby we are unable to include knowledge on environmental param-
eters of interest, such aswhether twin pairs were reared together, or in-
formation on e.g. the importance of the prodromal phase, which could
be relevant when addressing illness risk. In general, there may be a
twin diagnosis bias in which there is a higher probability for the second
twin to come to the attention of clinicians and thus be diagnosed, which
could partly explain the increased risk of schizophrenia in the second
twin. It is also possible that clinicians may be more attentive towards
families presenting with an early onset case. The use of a Danish twin
sample may limit the generalizability of our ﬁndings. In general it is as-
sumed that twins are representative for the general population (Rijsdijk
and Sham, 2002).
In conclusion, our examination of a large twin cohort indicates that
age at illness onset might be perceived as a clinical marker for increased
genetic vulnerability regarding schizophrenia spectrum. This is based
on the signiﬁcant association between increased illness risk and early
age at illness onset. Furthermore, female cases with early illness onset
may require an even stronger genetic contribution to express the illness
phenotype, indicating sex as a potential modiﬁer.
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